nodes	percent_of_prediction	percent_of_DWPC	metapath
Trandolapril—Mitiglinide—PPARG—liver cancer	0.0073	0.371	CrCbGaD
Trandolapril—Benazepril—MTHFR—liver cancer	0.00727	0.369	CrCbGaD
Trandolapril—Nateglinide—PPARG—liver cancer	0.00372	0.189	CrCbGaD
Trandolapril—Photosensitivity—Epirubicin—liver cancer	0.00294	0.003	CcSEcCtD
Trandolapril—Constipation—Sorafenib—liver cancer	0.00294	0.003	CcSEcCtD
Trandolapril—Eczema—Epirubicin—liver cancer	0.00287	0.00293	CcSEcCtD
Trandolapril—Gastrointestinal pain—Sorafenib—liver cancer	0.00281	0.00287	CcSEcCtD
Trandolapril—Renal failure acute—Epirubicin—liver cancer	0.0028	0.00285	CcSEcCtD
Trandolapril—Hot flush—Epirubicin—liver cancer	0.00276	0.00282	CcSEcCtD
Trandolapril—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.00275	0.0028	CcSEcCtD
Trandolapril—Menopausal symptoms—Epirubicin—liver cancer	0.00274	0.00279	CcSEcCtD
Trandolapril—Urticaria—Sorafenib—liver cancer	0.00273	0.00278	CcSEcCtD
Trandolapril—Photosensitivity—Doxorubicin—liver cancer	0.00272	0.00278	CcSEcCtD
Trandolapril—Abdominal pain—Sorafenib—liver cancer	0.00271	0.00277	CcSEcCtD
Trandolapril—Body temperature increased—Sorafenib—liver cancer	0.00271	0.00277	CcSEcCtD
Trandolapril—Eczema—Doxorubicin—liver cancer	0.00266	0.00271	CcSEcCtD
Trandolapril—Cardiac failure—Epirubicin—liver cancer	0.00265	0.0027	CcSEcCtD
Trandolapril—Cerebrovascular accident—Epirubicin—liver cancer	0.00263	0.00269	CcSEcCtD
Trandolapril—Hyponatraemia—Epirubicin—liver cancer	0.00259	0.00265	CcSEcCtD
Trandolapril—Renal failure acute—Doxorubicin—liver cancer	0.00259	0.00264	CcSEcCtD
Trandolapril—Osteoarthritis—Epirubicin—liver cancer	0.00258	0.00263	CcSEcCtD
Trandolapril—Pain in extremity—Epirubicin—liver cancer	0.00258	0.00263	CcSEcCtD
Trandolapril—Hot flush—Doxorubicin—liver cancer	0.00255	0.00261	CcSEcCtD
Trandolapril—Migraine—Epirubicin—liver cancer	0.00254	0.00259	CcSEcCtD
Trandolapril—Menopausal symptoms—Doxorubicin—liver cancer	0.00253	0.00258	CcSEcCtD
Trandolapril—Hypersensitivity—Sorafenib—liver cancer	0.00253	0.00258	CcSEcCtD
Trandolapril—Asthenia—Sorafenib—liver cancer	0.00246	0.00251	CcSEcCtD
Trandolapril—Cardiac arrest—Epirubicin—liver cancer	0.00246	0.00251	CcSEcCtD
Trandolapril—Cardiac failure—Doxorubicin—liver cancer	0.00245	0.0025	CcSEcCtD
Trandolapril—Cerebrovascular accident—Doxorubicin—liver cancer	0.00244	0.00249	CcSEcCtD
Trandolapril—Pruritus—Sorafenib—liver cancer	0.00243	0.00248	CcSEcCtD
Trandolapril—Blood creatinine increased—Epirubicin—liver cancer	0.00242	0.00247	CcSEcCtD
Trandolapril—Hyponatraemia—Doxorubicin—liver cancer	0.0024	0.00245	CcSEcCtD
Trandolapril—Osteoarthritis—Doxorubicin—liver cancer	0.00239	0.00244	CcSEcCtD
Trandolapril—Pain in extremity—Doxorubicin—liver cancer	0.00239	0.00244	CcSEcCtD
Trandolapril—Liver function test abnormal—Epirubicin—liver cancer	0.00238	0.00243	CcSEcCtD
Trandolapril—Dry skin—Epirubicin—liver cancer	0.00237	0.00242	CcSEcCtD
Trandolapril—Migraine—Doxorubicin—liver cancer	0.00235	0.0024	CcSEcCtD
Trandolapril—Diarrhoea—Sorafenib—liver cancer	0.00235	0.0024	CcSEcCtD
Trandolapril—Breast disorder—Epirubicin—liver cancer	0.00233	0.00238	CcSEcCtD
Trandolapril—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.00233	0.00237	CcSEcCtD
Trandolapril—Gastritis—Epirubicin—liver cancer	0.00229	0.00233	CcSEcCtD
Trandolapril—Alanine aminotransferase increased—Epirubicin—liver cancer	0.00228	0.00232	CcSEcCtD
Trandolapril—Cardiac arrest—Doxorubicin—liver cancer	0.00227	0.00232	CcSEcCtD
Trandolapril—Dizziness—Sorafenib—liver cancer	0.00227	0.00232	CcSEcCtD
Trandolapril—Abdominal distension—Epirubicin—liver cancer	0.00225	0.00229	CcSEcCtD
Trandolapril—Blood creatinine increased—Doxorubicin—liver cancer	0.00224	0.00228	CcSEcCtD
Trandolapril—Eosinophilia—Epirubicin—liver cancer	0.00221	0.00225	CcSEcCtD
Trandolapril—Liver function test abnormal—Doxorubicin—liver cancer	0.00221	0.00225	CcSEcCtD
Trandolapril—Dry skin—Doxorubicin—liver cancer	0.00219	0.00223	CcSEcCtD
Trandolapril—Pancreatitis—Epirubicin—liver cancer	0.00219	0.00223	CcSEcCtD
Trandolapril—Vomiting—Sorafenib—liver cancer	0.00218	0.00223	CcSEcCtD
Trandolapril—Angina pectoris—Epirubicin—liver cancer	0.00217	0.00222	CcSEcCtD
Trandolapril—Rash—Sorafenib—liver cancer	0.00217	0.00221	CcSEcCtD
Trandolapril—Dermatitis—Sorafenib—liver cancer	0.00216	0.00221	CcSEcCtD
Trandolapril—Breast disorder—Doxorubicin—liver cancer	0.00216	0.0022	CcSEcCtD
Trandolapril—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00215	0.0022	CcSEcCtD
Trandolapril—Headache—Sorafenib—liver cancer	0.00215	0.0022	CcSEcCtD
Trandolapril—Bronchitis—Epirubicin—liver cancer	0.00215	0.00219	CcSEcCtD
Trandolapril—Pancytopenia—Epirubicin—liver cancer	0.00212	0.00216	CcSEcCtD
Trandolapril—Gastritis—Doxorubicin—liver cancer	0.00211	0.00216	CcSEcCtD
Trandolapril—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.00211	0.00215	CcSEcCtD
Trandolapril—Neutropenia—Epirubicin—liver cancer	0.00209	0.00213	CcSEcCtD
Trandolapril—Abdominal distension—Doxorubicin—liver cancer	0.00208	0.00212	CcSEcCtD
Trandolapril—Upper respiratory tract infection—Epirubicin—liver cancer	0.00207	0.00212	CcSEcCtD
Trandolapril—Pollakiuria—Epirubicin—liver cancer	0.00206	0.0021	CcSEcCtD
Trandolapril—Eosinophilia—Doxorubicin—liver cancer	0.00204	0.00209	CcSEcCtD
Trandolapril—Nausea—Sorafenib—liver cancer	0.00204	0.00208	CcSEcCtD
Trandolapril—Photosensitivity reaction—Epirubicin—liver cancer	0.00204	0.00208	CcSEcCtD
Trandolapril—Pancreatitis—Doxorubicin—liver cancer	0.00202	0.00207	CcSEcCtD
Trandolapril—Hyperglycaemia—Epirubicin—liver cancer	0.00201	0.00205	CcSEcCtD
Trandolapril—Angina pectoris—Doxorubicin—liver cancer	0.00201	0.00205	CcSEcCtD
Trandolapril—Infestation NOS—Epirubicin—liver cancer	0.00199	0.00203	CcSEcCtD
Trandolapril—Infestation—Epirubicin—liver cancer	0.00199	0.00203	CcSEcCtD
Trandolapril—Drowsiness—Epirubicin—liver cancer	0.00199	0.00203	CcSEcCtD
Trandolapril—Bronchitis—Doxorubicin—liver cancer	0.00199	0.00203	CcSEcCtD
Trandolapril—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00197	0.00201	CcSEcCtD
Trandolapril—Pancytopenia—Doxorubicin—liver cancer	0.00196	0.002	CcSEcCtD
Trandolapril—Renal failure—Epirubicin—liver cancer	0.00196	0.002	CcSEcCtD
Trandolapril—Urinary tract infection—Epirubicin—liver cancer	0.00193	0.00197	CcSEcCtD
Trandolapril—Neutropenia—Doxorubicin—liver cancer	0.00193	0.00197	CcSEcCtD
Trandolapril—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00192	0.00196	CcSEcCtD
Trandolapril—Sweating—Epirubicin—liver cancer	0.00191	0.00195	CcSEcCtD
Trandolapril—Pollakiuria—Doxorubicin—liver cancer	0.00191	0.00195	CcSEcCtD
Trandolapril—Photosensitivity reaction—Doxorubicin—liver cancer	0.00188	0.00192	CcSEcCtD
Trandolapril—Hepatobiliary disease—Epirubicin—liver cancer	0.00188	0.00192	CcSEcCtD
Trandolapril—Epistaxis—Epirubicin—liver cancer	0.00188	0.00192	CcSEcCtD
Trandolapril—Hyperglycaemia—Doxorubicin—liver cancer	0.00186	0.0019	CcSEcCtD
Trandolapril—Agranulocytosis—Epirubicin—liver cancer	0.00186	0.00189	CcSEcCtD
Trandolapril—Drowsiness—Doxorubicin—liver cancer	0.00184	0.00188	CcSEcCtD
Trandolapril—Infestation NOS—Doxorubicin—liver cancer	0.00184	0.00188	CcSEcCtD
Trandolapril—Infestation—Doxorubicin—liver cancer	0.00184	0.00188	CcSEcCtD
Trandolapril—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00183	0.00186	CcSEcCtD
Trandolapril—Bradycardia—Epirubicin—liver cancer	0.00182	0.00186	CcSEcCtD
Trandolapril—Renal failure—Doxorubicin—liver cancer	0.00181	0.00185	CcSEcCtD
Trandolapril—Rhinitis—Epirubicin—liver cancer	0.00179	0.00183	CcSEcCtD
Trandolapril—Urinary tract infection—Doxorubicin—liver cancer	0.00179	0.00183	CcSEcCtD
Trandolapril—Hepatitis—Epirubicin—liver cancer	0.00179	0.00182	CcSEcCtD
Trandolapril—Pharyngitis—Epirubicin—liver cancer	0.00177	0.00181	CcSEcCtD
Trandolapril—Sweating—Doxorubicin—liver cancer	0.00177	0.0018	CcSEcCtD
Trandolapril—Urinary tract disorder—Epirubicin—liver cancer	0.00176	0.0018	CcSEcCtD
Trandolapril—Oedema peripheral—Epirubicin—liver cancer	0.00176	0.0018	CcSEcCtD
Trandolapril—Connective tissue disorder—Epirubicin—liver cancer	0.00176	0.00179	CcSEcCtD
Trandolapril—Urethral disorder—Epirubicin—liver cancer	0.00175	0.00179	CcSEcCtD
Trandolapril—Hepatobiliary disease—Doxorubicin—liver cancer	0.00174	0.00178	CcSEcCtD
Trandolapril—Epistaxis—Doxorubicin—liver cancer	0.00174	0.00177	CcSEcCtD
Trandolapril—Visual impairment—Epirubicin—liver cancer	0.00172	0.00176	CcSEcCtD
Trandolapril—Agranulocytosis—Doxorubicin—liver cancer	0.00172	0.00175	CcSEcCtD
Trandolapril—Erythema multiforme—Epirubicin—liver cancer	0.00169	0.00172	CcSEcCtD
Trandolapril—Bradycardia—Doxorubicin—liver cancer	0.00168	0.00172	CcSEcCtD
Trandolapril—Eye disorder—Epirubicin—liver cancer	0.00167	0.0017	CcSEcCtD
Trandolapril—Tinnitus—Epirubicin—liver cancer	0.00167	0.0017	CcSEcCtD
Trandolapril—Cardiac disorder—Epirubicin—liver cancer	0.00166	0.00169	CcSEcCtD
Trandolapril—Flushing—Epirubicin—liver cancer	0.00166	0.00169	CcSEcCtD
Trandolapril—Rhinitis—Doxorubicin—liver cancer	0.00166	0.00169	CcSEcCtD
Trandolapril—Hepatitis—Doxorubicin—liver cancer	0.00165	0.00169	CcSEcCtD
Trandolapril—Pharyngitis—Doxorubicin—liver cancer	0.00164	0.00167	CcSEcCtD
Trandolapril—Urinary tract disorder—Doxorubicin—liver cancer	0.00163	0.00167	CcSEcCtD
Trandolapril—Oedema peripheral—Doxorubicin—liver cancer	0.00163	0.00166	CcSEcCtD
Trandolapril—Connective tissue disorder—Doxorubicin—liver cancer	0.00162	0.00166	CcSEcCtD
Trandolapril—Angiopathy—Epirubicin—liver cancer	0.00162	0.00165	CcSEcCtD
Trandolapril—Urethral disorder—Doxorubicin—liver cancer	0.00162	0.00165	CcSEcCtD
Trandolapril—Immune system disorder—Epirubicin—liver cancer	0.00161	0.00165	CcSEcCtD
Trandolapril—Mediastinal disorder—Epirubicin—liver cancer	0.00161	0.00164	CcSEcCtD
Trandolapril—Arrhythmia—Epirubicin—liver cancer	0.0016	0.00163	CcSEcCtD
Trandolapril—Visual impairment—Doxorubicin—liver cancer	0.00159	0.00163	CcSEcCtD
Trandolapril—Alopecia—Epirubicin—liver cancer	0.00158	0.00161	CcSEcCtD
Trandolapril—Mental disorder—Epirubicin—liver cancer	0.00156	0.0016	CcSEcCtD
Trandolapril—Erythema multiforme—Doxorubicin—liver cancer	0.00156	0.00159	CcSEcCtD
Trandolapril—Malnutrition—Epirubicin—liver cancer	0.00155	0.00159	CcSEcCtD
Trandolapril—Eye disorder—Doxorubicin—liver cancer	0.00154	0.00158	CcSEcCtD
Trandolapril—Tinnitus—Doxorubicin—liver cancer	0.00154	0.00157	CcSEcCtD
Trandolapril—Flushing—Doxorubicin—liver cancer	0.00153	0.00157	CcSEcCtD
Trandolapril—Cardiac disorder—Doxorubicin—liver cancer	0.00153	0.00157	CcSEcCtD
Trandolapril—Flatulence—Epirubicin—liver cancer	0.00153	0.00156	CcSEcCtD
Trandolapril—Dysgeusia—Epirubicin—liver cancer	0.00152	0.00155	CcSEcCtD
Trandolapril—Back pain—Epirubicin—liver cancer	0.0015	0.00153	CcSEcCtD
Trandolapril—Angiopathy—Doxorubicin—liver cancer	0.0015	0.00153	CcSEcCtD
Trandolapril—Muscle spasms—Epirubicin—liver cancer	0.00149	0.00153	CcSEcCtD
Trandolapril—Immune system disorder—Doxorubicin—liver cancer	0.00149	0.00152	CcSEcCtD
Trandolapril—Mediastinal disorder—Doxorubicin—liver cancer	0.00149	0.00152	CcSEcCtD
Trandolapril—Arrhythmia—Doxorubicin—liver cancer	0.00148	0.00151	CcSEcCtD
Trandolapril—Alopecia—Doxorubicin—liver cancer	0.00146	0.00149	CcSEcCtD
Trandolapril—Mental disorder—Doxorubicin—liver cancer	0.00145	0.00148	CcSEcCtD
Trandolapril—Ill-defined disorder—Epirubicin—liver cancer	0.00144	0.00147	CcSEcCtD
Trandolapril—Malnutrition—Doxorubicin—liver cancer	0.00144	0.00147	CcSEcCtD
Trandolapril—Anaemia—Epirubicin—liver cancer	0.00144	0.00147	CcSEcCtD
Trandolapril—Agitation—Epirubicin—liver cancer	0.00143	0.00146	CcSEcCtD
Trandolapril—Flatulence—Doxorubicin—liver cancer	0.00142	0.00145	CcSEcCtD
Trandolapril—Dysgeusia—Doxorubicin—liver cancer	0.00141	0.00144	CcSEcCtD
Trandolapril—Malaise—Epirubicin—liver cancer	0.0014	0.00143	CcSEcCtD
Trandolapril—Nateglinide—ALB—liver cancer	0.0014	0.0711	CrCbGaD
Trandolapril—Vertigo—Epirubicin—liver cancer	0.0014	0.00143	CcSEcCtD
Trandolapril—Syncope—Epirubicin—liver cancer	0.00139	0.00142	CcSEcCtD
Trandolapril—Leukopenia—Epirubicin—liver cancer	0.00139	0.00142	CcSEcCtD
Trandolapril—Back pain—Doxorubicin—liver cancer	0.00139	0.00142	CcSEcCtD
Trandolapril—Muscle spasms—Doxorubicin—liver cancer	0.00138	0.00141	CcSEcCtD
Trandolapril—Palpitations—Epirubicin—liver cancer	0.00137	0.0014	CcSEcCtD
Trandolapril—Loss of consciousness—Epirubicin—liver cancer	0.00137	0.00139	CcSEcCtD
Trandolapril—Cough—Epirubicin—liver cancer	0.00136	0.00138	CcSEcCtD
Trandolapril—Ill-defined disorder—Doxorubicin—liver cancer	0.00133	0.00136	CcSEcCtD
Trandolapril—Anaemia—Doxorubicin—liver cancer	0.00133	0.00136	CcSEcCtD
Trandolapril—Chest pain—Epirubicin—liver cancer	0.00132	0.00135	CcSEcCtD
Trandolapril—Myalgia—Epirubicin—liver cancer	0.00132	0.00135	CcSEcCtD
Trandolapril—Arthralgia—Epirubicin—liver cancer	0.00132	0.00135	CcSEcCtD
Trandolapril—Agitation—Doxorubicin—liver cancer	0.00132	0.00135	CcSEcCtD
Trandolapril—Anxiety—Epirubicin—liver cancer	0.00132	0.00135	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00131	0.00134	CcSEcCtD
Trandolapril—Discomfort—Epirubicin—liver cancer	0.00131	0.00133	CcSEcCtD
Trandolapril—Malaise—Doxorubicin—liver cancer	0.0013	0.00132	CcSEcCtD
Trandolapril—Dry mouth—Epirubicin—liver cancer	0.00129	0.00132	CcSEcCtD
Trandolapril—Vertigo—Doxorubicin—liver cancer	0.00129	0.00132	CcSEcCtD
Trandolapril—Syncope—Doxorubicin—liver cancer	0.00129	0.00132	CcSEcCtD
Trandolapril—Leukopenia—Doxorubicin—liver cancer	0.00129	0.00131	CcSEcCtD
Trandolapril—Palpitations—Doxorubicin—liver cancer	0.00127	0.0013	CcSEcCtD
Trandolapril—Oedema—Epirubicin—liver cancer	0.00127	0.0013	CcSEcCtD
Trandolapril—Loss of consciousness—Doxorubicin—liver cancer	0.00126	0.00129	CcSEcCtD
Trandolapril—Infection—Epirubicin—liver cancer	0.00126	0.00129	CcSEcCtD
Trandolapril—Cough—Doxorubicin—liver cancer	0.00126	0.00128	CcSEcCtD
Trandolapril—Shock—Epirubicin—liver cancer	0.00125	0.00127	CcSEcCtD
Trandolapril—Nervous system disorder—Epirubicin—liver cancer	0.00124	0.00127	CcSEcCtD
Trandolapril—Thrombocytopenia—Epirubicin—liver cancer	0.00124	0.00127	CcSEcCtD
Trandolapril—Tachycardia—Epirubicin—liver cancer	0.00124	0.00126	CcSEcCtD
Trandolapril—Skin disorder—Epirubicin—liver cancer	0.00123	0.00126	CcSEcCtD
Trandolapril—Hyperhidrosis—Epirubicin—liver cancer	0.00123	0.00125	CcSEcCtD
Trandolapril—Arthralgia—Doxorubicin—liver cancer	0.00122	0.00125	CcSEcCtD
Trandolapril—Myalgia—Doxorubicin—liver cancer	0.00122	0.00125	CcSEcCtD
Trandolapril—Chest pain—Doxorubicin—liver cancer	0.00122	0.00125	CcSEcCtD
Trandolapril—Anxiety—Doxorubicin—liver cancer	0.00122	0.00125	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00122	0.00124	CcSEcCtD
Trandolapril—Discomfort—Doxorubicin—liver cancer	0.00121	0.00124	CcSEcCtD
Trandolapril—Anorexia—Epirubicin—liver cancer	0.00121	0.00123	CcSEcCtD
Trandolapril—Dry mouth—Doxorubicin—liver cancer	0.0012	0.00122	CcSEcCtD
Trandolapril—Hypotension—Epirubicin—liver cancer	0.00119	0.00121	CcSEcCtD
Trandolapril—Oedema—Doxorubicin—liver cancer	0.00117	0.0012	CcSEcCtD
Trandolapril—Infection—Doxorubicin—liver cancer	0.00117	0.00119	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00116	0.00118	CcSEcCtD
Trandolapril—Shock—Doxorubicin—liver cancer	0.00116	0.00118	CcSEcCtD
Trandolapril—Nervous system disorder—Doxorubicin—liver cancer	0.00115	0.00118	CcSEcCtD
Trandolapril—Thrombocytopenia—Doxorubicin—liver cancer	0.00115	0.00117	CcSEcCtD
Trandolapril—Insomnia—Epirubicin—liver cancer	0.00115	0.00117	CcSEcCtD
Trandolapril—Tachycardia—Doxorubicin—liver cancer	0.00115	0.00117	CcSEcCtD
Trandolapril—Skin disorder—Doxorubicin—liver cancer	0.00114	0.00116	CcSEcCtD
Trandolapril—Paraesthesia—Epirubicin—liver cancer	0.00114	0.00116	CcSEcCtD
Trandolapril—Hyperhidrosis—Doxorubicin—liver cancer	0.00114	0.00116	CcSEcCtD
Trandolapril—Dyspnoea—Epirubicin—liver cancer	0.00113	0.00115	CcSEcCtD
Trandolapril—Somnolence—Epirubicin—liver cancer	0.00113	0.00115	CcSEcCtD
Trandolapril—Anorexia—Doxorubicin—liver cancer	0.00112	0.00114	CcSEcCtD
Trandolapril—Dyspepsia—Epirubicin—liver cancer	0.00112	0.00114	CcSEcCtD
Trandolapril—Decreased appetite—Epirubicin—liver cancer	0.0011	0.00113	CcSEcCtD
Trandolapril—Hypotension—Doxorubicin—liver cancer	0.0011	0.00112	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Epirubicin—liver cancer	0.0011	0.00112	CcSEcCtD
Trandolapril—Fatigue—Epirubicin—liver cancer	0.00109	0.00112	CcSEcCtD
Trandolapril—Constipation—Epirubicin—liver cancer	0.00109	0.00111	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00107	0.00109	CcSEcCtD
Trandolapril—Insomnia—Doxorubicin—liver cancer	0.00106	0.00108	CcSEcCtD
Trandolapril—Paraesthesia—Doxorubicin—liver cancer	0.00105	0.00108	CcSEcCtD
Trandolapril—Dyspnoea—Doxorubicin—liver cancer	0.00105	0.00107	CcSEcCtD
Trandolapril—Feeling abnormal—Epirubicin—liver cancer	0.00105	0.00107	CcSEcCtD
Trandolapril—Somnolence—Doxorubicin—liver cancer	0.00104	0.00107	CcSEcCtD
Trandolapril—Gastrointestinal pain—Epirubicin—liver cancer	0.00104	0.00106	CcSEcCtD
Trandolapril—Dyspepsia—Doxorubicin—liver cancer	0.00103	0.00105	CcSEcCtD
Trandolapril—Decreased appetite—Doxorubicin—liver cancer	0.00102	0.00104	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00101	0.00103	CcSEcCtD
Trandolapril—Fatigue—Doxorubicin—liver cancer	0.00101	0.00103	CcSEcCtD
Trandolapril—Urticaria—Epirubicin—liver cancer	0.00101	0.00103	CcSEcCtD
Trandolapril—Constipation—Doxorubicin—liver cancer	0.001	0.00102	CcSEcCtD
Trandolapril—Abdominal pain—Epirubicin—liver cancer	0.001	0.00102	CcSEcCtD
Trandolapril—Body temperature increased—Epirubicin—liver cancer	0.001	0.00102	CcSEcCtD
Trandolapril—Feeling abnormal—Doxorubicin—liver cancer	0.000968	0.000987	CcSEcCtD
Trandolapril—Gastrointestinal pain—Doxorubicin—liver cancer	0.00096	0.00098	CcSEcCtD
Trandolapril—Hypersensitivity—Epirubicin—liver cancer	0.000935	0.000954	CcSEcCtD
Trandolapril—Urticaria—Doxorubicin—liver cancer	0.000933	0.000952	CcSEcCtD
Trandolapril—Abdominal pain—Doxorubicin—liver cancer	0.000928	0.000947	CcSEcCtD
Trandolapril—Body temperature increased—Doxorubicin—liver cancer	0.000928	0.000947	CcSEcCtD
Trandolapril—Asthenia—Epirubicin—liver cancer	0.000911	0.000929	CcSEcCtD
Trandolapril—Pruritus—Epirubicin—liver cancer	0.000898	0.000916	CcSEcCtD
Trandolapril—Diarrhoea—Epirubicin—liver cancer	0.000868	0.000886	CcSEcCtD
Trandolapril—Hypersensitivity—Doxorubicin—liver cancer	0.000865	0.000883	CcSEcCtD
Trandolapril—Asthenia—Doxorubicin—liver cancer	0.000842	0.00086	CcSEcCtD
Trandolapril—Dizziness—Epirubicin—liver cancer	0.000839	0.000856	CcSEcCtD
Trandolapril—Pruritus—Doxorubicin—liver cancer	0.000831	0.000848	CcSEcCtD
Trandolapril—Vomiting—Epirubicin—liver cancer	0.000807	0.000823	CcSEcCtD
Trandolapril—Diarrhoea—Doxorubicin—liver cancer	0.000803	0.00082	CcSEcCtD
Trandolapril—Rash—Epirubicin—liver cancer	0.0008	0.000817	CcSEcCtD
Trandolapril—Dermatitis—Epirubicin—liver cancer	0.000799	0.000816	CcSEcCtD
Trandolapril—Headache—Epirubicin—liver cancer	0.000795	0.000811	CcSEcCtD
Trandolapril—Dizziness—Doxorubicin—liver cancer	0.000776	0.000792	CcSEcCtD
Trandolapril—Nausea—Epirubicin—liver cancer	0.000754	0.000769	CcSEcCtD
Trandolapril—Vomiting—Doxorubicin—liver cancer	0.000747	0.000762	CcSEcCtD
Trandolapril—Rash—Doxorubicin—liver cancer	0.00074	0.000756	CcSEcCtD
Trandolapril—Dermatitis—Doxorubicin—liver cancer	0.00074	0.000755	CcSEcCtD
Trandolapril—Headache—Doxorubicin—liver cancer	0.000736	0.000751	CcSEcCtD
Trandolapril—Nausea—Doxorubicin—liver cancer	0.000697	0.000712	CcSEcCtD
Trandolapril—ACE—umbilical vein—liver cancer	0.000159	0.426	CbGeAlD
Trandolapril—CES1—gall bladder—liver cancer	9.83e-05	0.263	CbGeAlD
Trandolapril—ACE—embryo—liver cancer	4.15e-05	0.111	CbGeAlD
Trandolapril—CES1—liver—liver cancer	2.88e-05	0.0772	CbGeAlD
Trandolapril—SLC15A1—liver—liver cancer	2.68e-05	0.0716	CbGeAlD
Trandolapril—ACE—liver—liver cancer	1.92e-05	0.0513	CbGeAlD
